Delivery Order SPE2DB22D1002-SPE2DB25FLBX2

Award Date 5/7/25
Potential Completion Date 5/8/25
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRIVIACT 100 MG TABLET 60S. The order is valued at $6,104.90 and has a delivery deadline of October 15, 2024. The contract is a firm fixed-price, non-set-aside arrangement. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BRIVIACT 100 MG TABLET 60S, a medication, with a ceiling value of $1,857.38 and a period of performance through February 20, 2025. The contract is a firm fixed price, delivery order type with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,104.87, is for the supply of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product. The contract has a firm fixed price pricing type and a period of performance ending on February 5, 2025. The contract was not set aside for any particular business type. AmerisourceBergen holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of BRIVIACT 100 MG TABLET 60S, a medication, with a ceiling value of $1,305.85 and a completion date of January 29, 2025. The contract is a firm fixed-price, indefinite delivery type with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BRIVIACT 100 MG TABLET 60S, a specialty medication, with a ceiling value of $5,629.68 and a completion date of December 10, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRIVIACT 100 MG TABLET 60S. The contract has a ceiling value of $1,857.04 and runs through October 24, 2024. It is a Firm Fixed Price contract, with no set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and there is no information provided about any subcontractors. This contract is...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BRIVIACT 100 MG TABLET 60S, a prescription medication. The contract has a ceiling value of $2,848.01 and a period of performance through May 1, 2025. It is a firm-fixed-price, non-set-aside contract. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp. The delivery order is for the pharmaceutical product BRIVIACT 100 MG TABLET 60S, with a ceiling value of $2,645.87 and a completion date of December 30, 2024. The contract is a firm fixed-price arrangement, and there is no set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $2,690.40 and a period of performance through April 8, 2025. It is a delivery order contract for the purchase of BRIVIACT 75 MG TABLET 60S, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,322.79 and is for the supply of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product. It is a firm fixed-price delivery order contract with a completion date of December 27, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB25FLBX2
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,973.82, is for the delivery of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product, over the period ending on May 8, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 8/6/25, 9:48 AM